Summary
Definition
Overview
Recommendations in this article are consistent with the 2021 American Heart Association (AHA) guidelines on chest pain, and 2013 AHA guidelines on STEMI and NSTE-ACS. [1][2][3]
|
|
|
| ||
|
|
|
|
| |
|
| |
|
|
Subtypes of ACS cannot be differentiated based on clinical presentation alone.
Unstable angina is differentiated from MI by the presence of positive troponins, while the type of MI (NSTEMI vs. STEMI) is determined based on ECG findings.
Clinical features
- Classic presentation [5][6]
- Acute retrosternal
chest pain
- Typical: dull, squeezing pressure and/or tightness
- Commonly radiates to left chest, arm, shoulder, neck, jaw, and/or epigastrium
- Precipitated by exertion or stress
- Symptom relief after administration of nitrates is not a diagnostic criterion for cardiac ischemia. [2]
- The peak time of occurrence is usually in the morning.
- See also “Angina.”
- Dyspnea (especially with exertion)
- Pallor
- Nausea, vomiting
- Diaphoresis, anxiety
- Dizziness, lightheadedness, syncope
- Acute retrosternal
chest pain
- Other findings
- Tachycardia, arrhythmias
- Symptoms of CHF (e.g., orthopnea, pulmonary edema) or cardiogenic shock (e.g., hypotension, tachycardia, cold extremities)
- New heart murmur on auscultation (e.g., new S4)
- Atypical presentations: more likely in elderly, diabetic individuals, and women ;
[2][7]
- Stabbing, sharp chest pain
- No or minimal chest pain:
- Autonomic symptoms (e.g., nausea, diaphoresis)
- See also “Anginal equivalents.”
- More common in inferior wall
infarction
- Epigastric pain
- Bradycardia
- Clinical triad in right ventricular infarction: hypotension, elevated jugular venous pressure, clear lung fields [1]
Classically, it has been taught that STEMI manifests with more severe symptoms than NSTEMI, but this is not always the case.
Management approach
Diagnostics
Consider serial ECGs if the initial ECG is negative or inconclusive, as ECG findings are dynamic and signs of ischemia can appear or disappear within minutes.
Obtain a V7–V9 lead tracing if ST depressions are present in V1–V4, as this may be a sign of a posterior wall STEMI.
In patients with a normal ECG, a single result below the limit of detection using a high-sensitivity troponin assay ≥ 3 hours after symptom onset is considered sufficient to rule out myocardial infarction. [3]
TTE is generally not necessary and should not delay reperfusion therapy. However, it may be a helpful study in patients with atypical symptoms or if the diagnosis is unclear.
Do not delay treatment of ACS for imaging.
Risk stratification
STEMI
Avoid excluding a diagnosis of STEMI based on a single ECG as findings can change over time and with symptom fluctuation.
ECG changes in STEMI
Management
Acute management checklist
For patients < 120 min away from a PCI-capable facility
- Immediate cardiology consult and evaluation for emergency revascularization (code STEMI)
- Transfer to cath lab for angiography.
- Start
antiplatelets and anticoagulation (see “Antiplatelet therapy
and anticoagulation in STEMI”).
- Aspirin
- ADP receptor inhibitor (can also be given at time of PCI)
- Start anticoagulation with UFH, bivalirudin, or fondaparinux.
- Consider glycoprotein (GP) IIb/IIIa receptor antagonist.
For patients > 120 min away from a PCI-capable facility and symptom onset < 12 hours
- Immediate cardiology consult (code STEMI), even if no PCI is available
- Check for contraindications to fibrinolysis (see “Contraindications for fibrinolysis in STEMI and STEMI-equivalents”).
- If no absolute contraindications present: Administer fibrinolytic (see “Fibrinolytic therapy in STEMI”).
- Start
antiplatelets and anticoagulation (see “Antiplatelet therapy
and anticoagulation in STEMI”).
- Aspirin (as soon as possible)
- ADP receptor inhibitor: clopidogrel
- Start anticoagulation with UFH, enoxaparin, or fondaparinux.
- Postfibrinolysis: Evaluate for evidence of reperfusion (i.e., resolution of chest pain and ST-segment elevations).
- Transfer to a PCI-capable facility.
For all patients with STEMI
- Adjunctive medical therapy for
ACS
- Supplemental oxygen as needed: target SpO2 > 90%
- Nitroglycerin for patients with ongoing chest pain or hypertension
- Analgesia with morphine only for patients with very strong pain.
- High-intensity statin
- Consider a beta blocker if there are no contraindications.
- Consider an ACE inhibitor if there are no contraindications.
- Order continuous telemetry, serial ECG, and serum troponins every 4–6 hours.
- Consider ICU level of care
NSTEMI/UA
Overview
- Patients with NSTE-ACS are classified based on the presence (NSTEMI) or absence (UA) of significantly elevated cardiac troponin (cTn) levels.
- A key element of management is to assess the necessity for and timing of PCI (fibrinolytics are not indicated in NSTE-ACS).
- Hemodynamically unstable patients and those with intractable angina require immediate PCI (i.e., they are managed like STEMI patients).
- Multiple risk scores (e.g., HEART, TIMI, GRACE) can help to determine an adequate strategy but are no substitute for individual clinical judgment.
- Dual antiplatelet therapy and anticoagulation is indicated initially and the preferred regimens vary based on patient risk factors and timing of revascularization.
- Some low-risk NSTE-ACS patients can be managed conservatively.
ECG changes in NSTEMI/UA
- Findings [2]
- No ST elevations present
- Nonspecific signs of ischemia may be present, including:
- Additional considerations
- Normal ECG may be seen in up to 15% of patients with NSTEMI. [2][29]
- Be wary of STEMI-equivalent ECG findings (e.g., signs of posterior myocardial infarction) and repeat ECGs if inconclusive.
To identify STEMI or STEMI-equivalent ECG findings, repeat ECGs if the initial one is inconclusive or any changes in symptoms occur.
Management
The following recommendations are generally consistent with the 2014 AHA/ACC guidelines for the management of NSTE-ACS. [2]
Selection of an ischemia-guided strategy via shared decision-making may be appropriate in intermediate-risk patients without serious comorbidities or contraindications. [2]
Fibrinolytic therapy is not indicated in patients with unstable angina or NSTEMI.
Antiplatelet therapy and anticoagulation in NSTE-ACS [2]
Acute management checklist for NSTE-ACS
- Evaluate for very-high risk factors requiring urgent coronary angiography : If present, follow STEMI checklist. [2]
- Start
antiplatelet therapy and anticoagulation.
- Aspirin
- ADP receptor inhibitor: ticagrelor or clopidogrel
- Anticoagulation with UFH, enoxaparin, bivalirudin, or fondaparinux
- Calculate TIMI score and GRACE score.
- Cardiology consult for discussion of strategy (see “Risk-dependent timing of revascularization in NSTE-ACS”)
-
Adjunctive medical therapy for ACS
- Supplemental oxygen as needed: target SpO2 > 90%
- Nitroglycerin for patients with ongoing chest pain or hypertension
- Analgesia with morphine only for patients with very strong pain
- High-intensity statin
- Consider beta blocker if no contraindications.
- Consider ACE inhibitor if no contraindications.
- Order continuous telemetry, serial ECG, and serum troponins every 3–6 hours.
- Transfer to cardiac telemetry floor or (cardiac) ICU.
Monitoring and adjunctive medical therapy
Adjunct medical therapy in ACS [1][2]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options for initial MI treatment include “MONA-BASH”: Morphine, Oxygen, Nitroglycerin, Antiplatelet drugs (aspirin + ADP receptor inhibitor), Beta blockers, ACE inhibitors, Statins, and Heparin. The scope of interventions depends on the patient's risk profile (see “Indications”).
Supportive measures
- Oxygen therapy for patients with:
- Cyanosis
- Severe dyspnea
- SpO2 < 90%
- Fluid management: see “Management of acute heart failure.”
Disposition
STEMI [1]
Provide ICU-level care to all patients.
- At PCI-capable site: Consult cardiology immediately and transfer to cath lab as soon as possible for primary PCI.
- < 120 minutes from nearest PCI-capable site: Arrange immediate interfacility transfer for primary PCI at referral center.
- > 120 minutes from nearest PCI-capable site
- If symptom onset < 12 hours AND no contraindications to fibrinolysis for STEMI: Administer fibrinolytic prior to transfer to PCI-capable site.
- All other patients: Transfer to PCI-capable site.
NSTEMI and unstable angina [2]
- Cardiology consult
- Hospital admission
- Continuing angina, hemodynamic instability, uncontrolled arrhythmias, or large-territory MI: Admit to cardiac ICU.
- All other patients: Admit to step down unit.
- Assess risk-dependent timing of revascularization in NSTEMI and consider the need for transfer to the nearest PCI-capable site.
Negative initial workup for ACS [3]
If the initial evaluation for ACS is negative is inconclusive based on serial ECGs and cardiac troponin but clinical suspicion remains:
- Rule out other potential causes of chest pain.
- Use risk stratification for ACS (e.g., the HEART score) to determine the short-term risk of a MACE.
- Consider the need for observation or admission for further diagnostics based on the risk.
Risk-based management [3]
- High-risk (e.g., HEART score ≥ 7)
- Inpatient admission
- Obtain invasive coronary angiography during admission.
- Intermediate-risk (e.g.,
HEART score 4–6)
- Noninvasive testing (i.e., cardiac stress test or coronary CT angiography) is usually required prior to discharge.
- In patients with a recent negative workup for CAD , no further testing is indicated prior to discharge.
- Low-risk (e.g.,
HEART score ≤ 3)
- No further testing is indicated prior to discharge from the ED.
- Ensure outpatient follow-up.
- Outpatient coronary artery calcium scoring may be considered for ASCVD risk evaluation.
Differential diagnoses
Related One-Minute Telegram
Interested in the newest medical research, distilled down to just one minute? Sign up for the One-Minute Telegram in “Tips and links” below.
References
- Roffi M, Patrono C, Collet J-P, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2015; 37 (3): p.267-315. doi: 10.1093/eurheartj/ehv320 . | Open in Read by QxMD
- O’Gara PT, Kushner FG, et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. Circulation. 2013; 127 (4). doi: 10.1161/cir.0b013e3182742cf6 . | Open in Read by QxMD
- Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain. J Am Coll Cardiol. 2021; 78 (22): p.e187-e285. doi: 10.1016/j.jacc.2021.07.053 . | Open in Read by QxMD
- Amsterdam EA, Wenger NK, Brindis RG, et al.. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes. J Am Coll Cardiol. 2014 . doi: 10.1016/j.jacc.2014.09.017 . | Open in Read by QxMD
- Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2017; 39 (2): p.119-177. doi: 10.1093/eurheartj/ehx393 . | Open in Read by QxMD
- Collet J-P, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2020; 42 (14): p.1289-1367. doi: 10.1093/eurheartj/ehaa575 . | Open in Read by QxMD
- Wereski R, Kimenai DM, Taggart C, et al. Cardiac Troponin Thresholds and Kinetics to Differentiate Myocardial Injury and Myocardial Infarction. Circulation. 2021; 144 (7): p.528-538. doi: 10.1161/circulationaha.121.054302 . | Open in Read by QxMD
- Boeddinghaus J, Nestelberger T, Twerenbold R, et al. Direct Comparison of 4 Very Early Rule-Out Strategies for Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin I. Circulation. 2017; 135 (17): p.1597-1611. doi: 10.1161/circulationaha.116.025661 . | Open in Read by QxMD
- Fox KAA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006; 333 (7578): p.1091. doi: 10.1136/bmj.38985.646481.55 . | Open in Read by QxMD
- Fox KAA, FitzGerald G, Puymirat E, et al. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score. BMJ Open. 2014; 4 (2): p.e004425. doi: 10.1136/bmjopen-2013-004425 . | Open in Read by QxMD
- Six AJ, Backus BE, Kelder JC. Chest pain in the emergency room: value of the HEART score. Netherlands Heart Journal. 2008; 16 (6): p.191-196. doi: 10.1007/bf03086144 . | Open in Read by QxMD
- McCord J, Cabrera R, Lindahl B, et al. Prognostic Utility of a Modified HEART Score in Chest Pain Patients in the Emergency Department. Circ Cardiovasc Qual Outcomes. 2017; 10 (2). doi: 10.1161/circoutcomes.116.003101 . | Open in Read by QxMD
- Mahler SA, Stopyra JP, Apple FS, et al. Use of the HEART Pathway with high sensitivity cardiac troponins: A secondary analysis. Clin Biochem. 2017; 50 (7-8): p.401-407. doi: 10.1016/j.clinbiochem.2017.01.003 . | Open in Read by QxMD
- Mahler SA, Riley RF, Hiestand BC, et al. The HEART Pathway Randomized Trial. Circ Cardiovasc Qual Outcomes. 2015; 8 (2): p.195-203. doi: 10.1161/circoutcomes.114.001384 . | Open in Read by QxMD
- Ramjane Khalill, MD, Lei Han, MD, Chang Jing, PhD, and He Quan, PhD. The use of risk scores for stratification of non-ST elevation acute coronary syndrome patients. Experimental & Clinical Cardiology. 2009 .
- Antman EM, Cohen M, Bernink PJLM, et al. The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI. JAMA. 2000; 284 (7): p.835. doi: 10.1001/jama.284.7.835 . | Open in Read by QxMD
- Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 130 : p.e344-e426. doi: 10.1161/CIR.0000000000000134 . | Open in Read by QxMD
- Braunwald E. Unstable angina and non–ST elevation myocardial infarction. Am J Respir Crit Care Med. 2012; 185 (9): p.924-932. doi: 10.1164/rccm.201109-1745ci . | Open in Read by QxMD
- Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J. Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2). McGraw-Hill Education / Medical ; 2018
- Walls R, Hockberger R, Gausche-Hill M. Rosen's Emergency Medicine. Elsevier Health Sciences ; 2018
- Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018; 72 (18): p.2231-2264. doi: 10.1016/j.jacc.2018.08.1038 . | Open in Read by QxMD
- Montalescot G, Pitt B, Lopez de Sa E, et al. Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: The Randomized Double-Blind Reminder Study. Eur Heart J. 2014; 35 (34): p.2295-2302. doi: 10.1093/eurheartj/ehu164 . | Open in Read by QxMD
- Kjell Nikus, Yochai Birnbaum, Markku Eskola, Samuel Sclarovsky, Zhan Zhong-qun, and Olle Pahlm. Updated Electrocardiographic Classification of Acute Coronary Syndromes. Current Cardiology Reviews. 2014 .
- Chang AM, Shofer FS, Tabas JA, Magid DJ, McCusker CM, Hollander JE. Lack of association between left bundle-branch block and acute myocardial infarction in symptomatic ED patients. Am J Emerg Med. 2009; 27 (8): p.916-921. doi: 10.1016/j.ajem.2008.07.007 . | Open in Read by QxMD
- Widimsky P, Rohac F, Stasek J, et al. Primary angioplasty in acute myocardial infarction with right bundle branch block: should new onset right bundle branch block be added to future guidelines as an indication for reperfusion therapy?. Eur Heart J. 2011; 33 (1): p.86-95. doi: 10.1093/eurheartj/ehr291 . | Open in Read by QxMD
- Sgarbossa EB, Pinski SL, Barbagelata A, et al. Electrocardiographic Diagnosis of Evolving Acute Myocardial Infarction in the Presence of Left Bundle-Branch Block. N Engl J Med. 1996; 334 (8): p.481-487. doi: 10.1056/nejm199602223340801 . | Open in Read by QxMD
- Smith SW, Dodd KW, Henry TD, Dvorak DM, Pearce LA. Diagnosis of ST-Elevation Myocardial Infarction in the Presence of Left Bundle Branch Block With the ST-Elevation to S-Wave Ratio in a Modified Sgarbossa Rule. Ann Emerg Med. 2012; 60 (6): p.766-776. doi: 10.1016/j.annemergmed.2012.07.119 . | Open in Read by QxMD
- Nikus K, Pahlm O, Wagner G, et al. Electrocardiographic classification of acute coronary syndromes: a review by a committee of the International Society for Holter and Non-Invasive Electrocardiology. J Electrocardiol. 2010; 43 (2): p.91-103. doi: 10.1016/j.jelectrocard.2009.07.009 . | Open in Read by QxMD
- Switaj TL, et al. Acute Coronary Syndrome: Current Treatment.. Am Fam Physician. 2017; 95 (4): p.232-240.
- Squire IB, et al. Humoral and cellular immune responses up to 7·5 years after administration of streptokinase for acute myocardial infarction. Eur Heart J. 1999; 20 (17): p.1245-1252. doi: 10.1053/euhj.1999.1528 . | Open in Read by QxMD
- Kasper DL, Fauci AS, Hauser SL, Longo DL, Lameson JL, Loscalzo J. Harrison's Principles of Internal Medicine. McGraw-Hill Education ; 2015
- Le T, Bhushan V, Chen V, King M. First Aid for the USMLE Step 2 CK. McGraw-Hill Education ; 2015
- Marx JA, Hockberger RS, Walls RM et al. Rosen's Emergency Medicine - Concepts and Clinical Practice. Saunders ; 2013
- Reeder GS, Awtry E, Mahler SA. Initial evaluation and management of suspected acute coronary syndrome (myocardial infarction, unstable angina) in the emergency department. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. //www.uptodate.com/contents/initial-evaluation-and-management-of-suspected-acute-coronary-syndrome-myocardial-infarction-unstable-angina-in-the-emergency-department?source=machineLearning&search=atypical%20Mi%20causes&selectedTitle=2~150§ionRank=1&anchor=H14#H14.Last updated: October 3, 2016. Accessed: February 22, 2017.
- Goljan EF. Rapid Review Pathology. Elsevier Saunders ; 2018
- Le T, Bhushan V, Sochat M, Chavda Y, Zureick A. First Aid for the USMLE Step 1 2018. McGraw-Hill Medical ; 2017
- European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones.. J Hepatol. 2016; 65 (1): p.146-181. doi: 10.1016/j.jhep.2016.03.005 . | Open in Read by QxMD
- Tao Le, Vikas Bhushan, Deol M, Reyes G. First Aid for the USMLE Step 2 CK, Tenth Edition. McGraw-Hill Education ; 2018
- Wu S-D. Effects of narcotic analgesic drugs on human Oddi’s sphincter motility. World Journal of Gastroenterology. 2004; 10 (19): p.2901. doi: 10.3748/wjg.v10.i19.2901 . | Open in Read by QxMD
- Thune A, Baker RA, Saccone GTP, Owen H, Toouli J. Differing effects of pethidine and morphine on human sphincter of Oddi motility. Br J Surg. 1990; 77 (9): p.992-995. doi: 10.1002/bjs.1800770911 . | Open in Read by QxMD
- Masudi T, Capitelli-McMahon H, Anwar S. Acute pain management in symptomatic cholelithiasis. World Journal of Gastrointestinal Surgery. 2016; 8 (10): p.713. doi: 10.4240/wjgs.v8.i10.713 . | Open in Read by QxMD
- Barr J, Fraser GL, Puntillo K, et al. Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit. Crit Care Med. 2013; 41 (1): p.263-306. doi: 10.1097/ccm.0b013e3182783b72 . | Open in Read by QxMD
- Schrör K, Nitschmann S. Kardiovaskuläre Sicherheit von Celecoxib. Internist (Berl). 2017; 58 (8): p.863-865. doi: 10.1007/s00108-017-0260-x . | Open in Read by QxMD
- Blondell RD, Azadfard M et al.. Pharmacologic therapy for acute pain.. Am Fam Physician. 2013; 87 (11): p.766-72.
- McCarberg BH, Argoff CE. Topical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injury. Int J Clin Pract. 2010; 64 (11): p.1546-1553. doi: 10.1111/j.1742-1241.2010.02474.x . | Open in Read by QxMD
- Blondell R, Azadfard M, Wisniewski A. Pharmacologic Therapy for Acute Pain. Am Fam Physician.. 2013 .
- Rushfeldt CF, Sveinbjørnsson B, Søreide K, Vonen B. Risk of anastomotic leakage with use of NSAIDs after gastrointestinal surgery. Int J Colorectal Dis. 2011; 26 (12): p.1501-1509. doi: 10.1007/s00384-011-1285-6 . | Open in Read by QxMD
- Jain S, Ting HT, Bell M, et al. Utility of Left Bundle Branch Block as a Diagnostic Criterion for Acute Myocardial Infarction. Am J Cardiol. 2011; 107 (8): p.1111-1116. doi: 10.1016/j.amjcard.2010.12.007 . | Open in Read by QxMD
- Khanna IK, Pillarisetti S. Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic pain.. Journal of pain research. 2015; 8 : p.859-70. doi: 10.2147/JPR.S85951 . | Open in Read by QxMD